GBIO
Price
$5.99
Change
+$0.21 (+3.63%)
Updated
Sep 5 closing price
Capitalization
40.35M
60 days until earnings call
SANA
Price
$2.96
Change
-$0.02 (-0.67%)
Updated
Sep 5 closing price
Capitalization
751.52M
60 days until earnings call
Interact to see
Advertisement

GBIO vs SANA

Header iconGBIO vs SANA Comparison
Open Charts GBIO vs SANABanner chart's image
Generation Bio
Price$5.99
Change+$0.21 (+3.63%)
Volume$46.83K
Capitalization40.35M
Sana Biotechnology
Price$2.96
Change-$0.02 (-0.67%)
Volume$3.61M
Capitalization751.52M
GBIO vs SANA Comparison Chart in %
Loading...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SANA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GBIO vs. SANA commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GBIO is a StrongBuy and SANA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (GBIO: $5.99 vs. SANA: $2.96)
Brand notoriety: GBIO and SANA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GBIO: 10% vs. SANA: 66%
Market capitalization -- GBIO: $40.35M vs. SANA: $751.52M
GBIO [@Biotechnology] is valued at $40.35M. SANA’s [@Biotechnology] market capitalization is $751.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GBIO’s FA Score shows that 0 FA rating(s) are green whileSANA’s FA Score has 0 green FA rating(s).

  • GBIO’s FA Score: 0 green, 5 red.
  • SANA’s FA Score: 0 green, 5 red.
According to our system of comparison, SANA is a better buy in the long-term than GBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GBIO’s TA Score shows that 3 TA indicator(s) are bullish while SANA’s TA Score has 4 bullish TA indicator(s).

  • GBIO’s TA Score: 3 bullish, 5 bearish.
  • SANA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SANA is a better buy in the short-term than GBIO.

Price Growth

GBIO (@Biotechnology) experienced а -0.17% price change this week, while SANA (@Biotechnology) price change was -3.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

GBIO is expected to report earnings on Nov 05, 2025.

SANA is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SANA($752M) has a higher market cap than GBIO($40.3M). SANA YTD gains are higher at: 81.595 vs. GBIO (-43.491). GBIO has higher annual earnings (EBITDA): -69.92M vs. SANA (-197.36M). GBIO has more cash in the bank: 141M vs. SANA (72.7M). GBIO (85.3M) and SANA (85.5M) have identical debt. GBIO has higher revenues than SANA: GBIO (21.2M) vs SANA (0).
GBIOSANAGBIO / SANA
Capitalization40.3M752M5%
EBITDA-69.92M-197.36M35%
Gain YTD-43.49181.595-53%
P/E RatioN/AN/A-
Revenue21.2M0-
Total Cash141M72.7M194%
Total Debt85.3M85.5M100%
TECHNICAL ANALYSIS
Technical Analysis
GBIOSANA
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
86%
Bullish Trend 16 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SANA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NMTC0.790.06
+8.47%
NeuroOne Medical Technologies Corp
ETNB8.870.26
+3.02%
89bio
WILC20.170.36
+1.79%
G Willi-Food International Ltd
AMGN283.643.54
+1.26%
Amgen
GDS33.170.41
+1.25%
GDS Holdings Limited

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with CABA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then CABA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
+3.63%
CABA - GBIO
47%
Loosely correlated
+10.39%
MGNX - GBIO
45%
Loosely correlated
+3.09%
OVID - GBIO
43%
Loosely correlated
-4.65%
SYRE - GBIO
43%
Loosely correlated
+0.06%
FATE - GBIO
42%
Loosely correlated
+3.81%
More